The 2025 Controlled & Modified Drug Release Summit in New Brunswick, NJ on May 7-8 will feature over 150 senior drug development experts, decision-makers, and innovators.
The 11th Annual Summit on Innovations in Controlled Release, Bioavailability Enhancement & Continuous Manufacturing focuses on the latest in formulation, product development, and delivery technologies for improving performance and manufacuring capabilities. The event will feature two tracks of technical talks, panels, and discussions, plus exhibitions and networking opporunties.
AbbVie Contract Manufacturing provides services including pharma Hot Melt Extrusion (HME). HME enhances the bioavailability of poorly soluble APIs. From drug development to final packaging, AbbVie Contract Manufacturing is a partner with decades of exerperience that can navigate the challenges of commercial ready production, regulatory compliance, and ongoing supply chain security.
Planning to attend? Meet us there.
Event: 2025 Controlled & Modified Drug Release Summit
Date: May 7-8, 2025
Location: New Brunswick, New Jersey, USA
